Ibuprofen Tapering for Pericarditis
For ibuprofen 800 mg TID in acute pericarditis, decrease the dose by 200-400 mg every 1-2 weeks after symptoms resolve and CRP normalizes, typically starting the taper after 1-2 weeks of full-dose therapy. 1
Tapering Protocol
The 2015 ESC Guidelines provide explicit tapering recommendations for ibuprofen in pericarditis 1:
- Starting dose: 600 mg every 8 hours (standard guideline dose)
- Your dose of 800 mg TID: This is higher than the guideline-recommended 600 mg TID, but falls within the acceptable range of 1200-2400 mg daily 1
- Treatment duration at full dose: 1-2 weeks for uncomplicated cases
- Tapering schedule: Decrease by 200-400 mg every 1-2 weeks
Practical Tapering Example for 800 mg TID (2400 mg/day):
Week 1-2: 800 mg TID (2400 mg/day) - maintain until symptoms resolve and CRP normalizes
Week 3-4: 600 mg TID (1800 mg/day) - reduce by 600 mg total daily dose
Week 5-6: 400 mg TID (1200 mg/day) - reduce by another 600 mg
Week 7-8: 400 mg BID (800 mg/day) - reduce by 400 mg
Week 9: 400 mg daily (400 mg/day) - reduce by 400 mg
Week 10: Discontinue
Critical Timing Considerations
Do not begin tapering until BOTH conditions are met 1:
- Complete resolution of symptoms (chest pain)
- Normalization of C-reactive protein (CRP)
The initial full dose should be maintained until these markers normalize, which typically occurs within 1-2 weeks for uncomplicated cases 1. CRP should be monitored to guide treatment length and assess response 1.
Important Caveats
Longer Tapering for Recurrent Cases
For recurrent pericarditis, the guidelines recommend "longer tapering times for more difficult, resistant cases may be considered" 1. In these situations, you may need to extend each tapering interval beyond 1-2 weeks.
Colchicine Co-Administration
Colchicine should be added to ibuprofen therapy (Class I, Level A recommendation) 1. The guidelines are explicit that colchicine is recommended as first-line adjunctive therapy to improve response and prevent recurrences 1. Colchicine should be continued for 3 months and does not require mandatory tapering 1.
Gastroprotection
Always provide gastroprotection with proton pump inhibitors or H2 blockers throughout the entire treatment course 1.
Risk of Inadequate Treatment
A common cause of recurrence is inadequate treatment of the first episode 1. The recurrence rate after initial pericarditis ranges from 15-30%, but can increase to 50% after a first recurrence if not treated with colchicine 1. Too-rapid tapering increases recurrence risk, so err on the side of slower tapering if symptoms persist or CRP remains elevated.
When to Slow or Stop Tapering
If symptoms recur or CRP rises during tapering, do not continue reducing the dose 1. Return to the previous effective dose, maintain until symptoms resolve and CRP normalizes again, then attempt a slower taper.
Cardiovascular Safety
Recent evidence suggests ibuprofen use for acute pericarditis is not associated with increased cardiovascular risks, supporting its safety even at higher doses 2.